Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Dalfampridine	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[2]  4 , 13 💬
2	Dalfampridine er	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
3	Dalfampridine-er 10mg	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
4	Dalfampridine-er 5mg	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
5	Fampyra	-	-	-	-	[2] 13, 14 💬
6	Fampyra - 10 mg - compressa a rilascio prolungato - uso orale - flacone (hdpe) 56 compresse (4 flaconi da 14)	-	-	-	-	[1] 13 💬
7	Fampyra 10 mg prolonged-release tablets	-	-	-	-	[1] 13 💬
8	Fampyra 10mg prolonged release tablets	-	-	-	-	[1] 13 💬
9	Other: withdrawal of dalfampridine-er 10mg	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
10	Sustained-release oral dalfampridine	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬